Clinical Trials for Kamau Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Kamau Therapeutics

Clinical Trials (1)

NCT04819841
Gene Correction in Autologous CD34+ Hematopoietic Stem Cells (HbS to HbA) to Treat Severe Sickle Cell Disease
PHASE1/PHASE2Recruiting
15 participants
Started: Nov 15, 2021 · Completed: Dec 31, 2028
1 condition1 sponsor3 locations